Market Definition 

Nanobots in the medical industry offer nanomedicine to fight chronic diseases such as cancer. Nanomedicine utilizes the knowledge of nanotechnology to prevent and treat severe diseases such as cancer and heart diseases. 

Global nanorobotics market is estimated to reach $XX million by 2026; growing at a CAGR of XX% till 2026. 

Market Dynamics 

Increasing research studies and development of nanorobotics is driving the market. For instance, scientists in the U.S. and China have developed programmable DNA origami nanorobots that can seek out and shrink tumors by blocking the blood supply. The scientists have tested in mice carrying breast, melanoma, ovarian, and lung tumors showed how the DNA nanorobots homed in cancer-feeding blood vessels. The results included stunted tumor growth, shrinkage of existing tumors and metastasis, and inhibition of metastases. Additionally, researchers from ITMO University has conducted new research on the drug against cancer, a nanorobot made of DNA fragments, which can be used to destroy cancer cells and also to locate them in the body. Further, increasing investment in developing nanobots is a key driving factor of the market. However, high development cost of nanobots might hamper the market growth. Moreover, technological advancements in nanorobotics for medical use would provide lucrative opportunities for the market in the coming years. 

Market Segmentation 

The global nanorobotics market is mainly classified based on product type and applications. Product type is further segmented into Microbivore Nanorobots, Respirocyte Nanorobots, Clottocyte Nanorobots, Cellular Repair Nanorobots, and Others. By applications, the market is divided into NanoMedicine, Biomedical, and Others.  

Microbivore Nanorobots is expected to show significant growth in the forecasting years, due to the design to be much faster at destroying bacteria, helps to eliminate bacterial infections in the patient within minutes. Microbivore nanorobots are designed so that antibodies attach to the bacteria the robot is seeking, an arm grabs the bacteria and moves it inside of the nanorobot, where it is destroyed. The bacteria are then discharged into the bloodstream as a harmless fragment. 

Regional Analysis 

Based on geography, the global nanorobotics market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa. 

North America was dominating the global nanorobotics market in 2019, owing to the collaboration between companies to develop nanorobotics for the healthcare industry, increasing investment by the companies for the research and development of nanorobotics, and increasing research studies in nanorobotics. For instance, Michigan State University scientists have created a process-based magnetic particle imaging (MPI) employs superparamagnetic nanoparticles as the contrast agent and the signal source to monitor drug release in the body, at the site of the tumor. The noninvasive helps the doctor to provide immediate quantitative visualization of how the drug is being distributed in the body 

Competitive landscape 

Key players operating in the nanorobotics industry include EV Group, Agilent Technologies, Electrovac, Bruker Corporation, Park Systems Corporation, JEOL Ltd, Anasys Instruments, FEI Company, AIXTRON SE, Novascan Technologies, Asylum Research, and NT-MDT. 

The strategic acquisition to expand the nanorobotics business, the partnership between companies to develop nanorobotics, increasing research studies on nanorobotics, and rising investment in researching and developing nanorobotics are some of the strategies adopted by the major companies. Many startups companies are emerging in the new medical field. One of those is Pumeram, which has raised €11.5 million to develop rocket, spheroid and even screw-shaped nanobots to help treat diseases ranging from skin and oral ailments to fertility problems. The startup’s cancer-killing nanobots have been successfully tested on mice. 

Nanorobotics Market Key Segments: 

By Product Type 

• Microbivore Nanorobots 
• Respirocyte Nanorobots 
• Clottocyte Nanorobots 
• Cellular Repair Nanorobots 
• Others 

By Applications 

• NanoMedicine 
• Biomedical 
• Others 

Key Global Nanorobotics Industry Players 

• EV Group 
• Agilent Technologies 
• Electrovac 
• Bruker Corporation 
• Park Systems Corporation 
• JEOL Ltd 
• Anasys Instruments 
• FEI Company 
• AIXTRON SE 
• Novascan Technologies 
• Asylum Research 
• NT-MDT 

What Report Provides 

• Full in-depth analysis of the parent Industry 
• Important changes in market and its dynamics 
• Segmentation details of the market 
• Former, on-going, and projected market analysis in terms of volume and value 
• Assessment of niche industry developments 
• Market share analysis 
• Key strategies of major players 
• Emerging segments and regional growth potential